Association of visual function and ganglion cell layer thickness in patients with diabetes mellitus type 1 and no or minimal diabetic retinopathy

Vision Research

Volumn 51, Issue 2, 2011, Pages 224-228

  van Dijk, Hille W ^a   Verbraak, Frank D ^a   Stehouwer, Marilette ^a   Kok, Pauline H B ^a   Garvin, Mona K ^b   Sonka, Milan ^b,c   DeVries, J Hans ^a   Schlingemann, Reinier O ^a   Abràmoff, Michael D ^b,c,d  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Diabetic neurodegeneration; Diabetic retinopathy; Ganglion cell layer; Retina; Visual function

Indexed keywords

ADULT; ARTICLE; CELLULAR PARAMETERS; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; DIABETIC RETINOPATHY; FEMALE; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NERVE DEGENERATION; OPTICAL COHERENCE TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; RETINA GANGLION CELL; RETINA MACULOPATHY; VISUAL DISORDER; VISUAL FIELD;

ADULT; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; FEMALE; HUMANS; MACULA LUTEA; MALE; MIDDLE AGED; RETINAL GANGLION CELLS; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY; VISUAL FIELDS; YOUNG ADULT;

EID: 78651468742     PISSN: 00426989     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.visres.2010.08.024     Document Type: Article

References (48)

1. Early Treatment Diabetic Retinopathy Study Research Group Grading diabetic retinopathy from stereoscopic color fundus photographs - An extension of the modified Airlie House classification. ETDRS report number 10. Ophthalmology 1991, 98:786-806.
2. Abràmoff M., Magalhâes P., Ram S. Image processing with image. Journal of Biophotonics 2004, 11:36-42.
3. Abu-El-Asrar A.M., Dralands L., Missotten L., Al-Jadaan I.A., Geboes K. Expression of apoptosis markers in the retinas of human subjects with diabetes. Investigative Ophthalmology and Visual Science 2004, 45:2760-2766.
4. Antonetti D.A., Barber A.J., Bronson S.K., Freeman W.M., Gardner T.W., Jefferson L.S., et al. Diabetic retinopathy: Seeing beyond glucose-induced microvascular disease. Diabetes 2006, 55:2401-2411.
5. Asefzadeh B., Fisch B.M., Parenteau C.E., Cavallerano A.A. Macular thickness and systemic markers for diabetes in individuals with no or mild diabetic retinopathy. Clinical and Experimental Ophthalmology 2008, 36:455-463.
6. Barber A.J. A new view of diabetic retinopathy: A neurodegenerative disease of the eye. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2003, 27:283-290.
7. Barber A.J., Antonetti D.A., Kern T.S., Reiter C.E., Soans R.S., Krady J.K., et al. The Ins2Akita mouse as a model of early retinal complications in diabetes. Investigative Ophthalmology and Visual Science 2005, 46:2210-2218.
8. Barber A.J., Lieth E., Khin S.A., Antonetti D.A., Buchanan A.G., Gardner T.W. Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. Journal of Clinical Investigation 1998, 102:783-791.
9. Bearse M.A., Adams A.J., Han Y., Schneck M.E., Ng J., Bronson-Castain K., et al. A multifocal electroretinogram model predicting the development of diabetic retinopathy. Progress in Retinal and Eye Research 2006, 25:425-448.
10. Biallosterski C., van Velthoven M.E., Michels R.P., Schlingemann R.O., DeVries J.H., Verbraak F.D. Decreased optical coherence tomography-measured pericentral retinal thickness in patients with diabetes mellitus type 1 with minimal diabetic retinopathy. British Journal of Ophthalmology 2007, 91:1135-1138.
11. Bronson-Castain K.W., Bearse M.A., Neuville J., Jonasdottir S., King-Hooper B., Barez S., et al. Adolescents with type 2 diabetes: early indications of focal retinal neuropathy, retinal thinning, and venular dilation. Retina 2009, 29:618-626.
12. Browning D.J., Fraser C.M., Clark S. The relationship of macular thickness to clinically graded diabetic retinopathy severity in eyes without clinically detected diabetic macular edema. Ophthalmology 2008, 115:533-539.
13. Di Leo M.A., Caputo S., Falsini B., Porciatti V., Minnella A., Greco A.V., et al. Nonselective loss of contrast sensitivity in visual system testing in early type I diabetes. Diabetes Care 1992, 15:620-625.
14. Dosso A.A., Bonvin E.R., Morel Y., Golay A., Assal J.P., Leuenberger P.M. Risk factors associated with contrast sensitivity loss in diabetic patients. Graefes Archive for Clinical and Experimental Ophthalmology 1996, 234:300-305.
15. Fischer B. Overlap of receptive field centers and representation of the visual field in the cat's optic tract. Vision Research 1973, 13:2113-2120.
16. Fong D.S., Aiello L., Gardner T.W., King G.L., Blankenship G., Cavallerano J.D., et al. Retinopathy in diabetes. Diabetes Care 2004, 27(Suppl. 1):S84-S87.
17. Frisen L. New, sensitive window on abnormal spatial vision: Rarebit probing. Vision Research 2002, 42:1931-1939.
18. Frisen L., Quigley H.A. Visual acuity in optic atrophy: A quantitative clinicopathological analysis. Graefes Archive for Clinical and Experimental Ophthalmology 1984, 222:71-74.
19. Gardner T.W., Antonetti D.A., Barber A.J., LaNoue K.F., Levison S.W. Diabetic retinopathy: More than meets the eye. Survey of Ophthalmology 2002, 47(Suppl. 2):S253-S262.
20. Garvin M.K., Abramoff M.D., Kardon R., Russell S.R., Wu X., Sonka M. Intraretinal layer segmentation of macular optical coherence tomography images using optimal 3-D graph search. IEEE Transactions on Medical Imaging 2008, 27:1495-1505.
21. Garvin M., Abramoff M., Wu X., Russell S., Burns T., Sonka M. Automated 3-D intraretinal layer segmentation of macular spectral-domain optical coherence tomography images. IEEE Transactions on Medical Imaging 2009, 28:1436-1447.
22. Gastinger M.J., Kunselman A.R., Conboy E.E., Bronson S.K., Barber A.J. Dendrite remodeling and other abnormalities in the retinal ganglion cells of Ins2 Akita diabetic mice. Investigative Ophthalmology and Visual Science 2008, 49:2635-2642.
23. Gastinger M.J., Singh R.S., Barber A.J. Loss of cholinergic and dopaminergic amacrine cells in streptozotocin-diabetic rat and Ins2Akita-diabetic mouse retinas. Investigative Ophthalmology and Visual Science 2006, 47:3143-3150.
24. Hardy K.J., Lipton J., Scase M.O., Foster D.H., Scarpello J.H. Detection of colour vision abnormalities in uncomplicated type 1 diabetic patients with angiographically normal retinas. British Journal of Ophthalmology 1992, 76:461-464.
25. Hood D.C., Kardon R.H. A framework for comparing structural and functional measures of glaucomatous damage. Progress in Retinal and Eye Research 2007, 26:688-710.
26. Kern T.S., Barber A.J. Retinal ganglion cells in diabetes. Journal of Physiology 2008, 15:4401-4408.
27. Kerrigan-Baumrind L.A., Quigley H.A., Pease M.E., Kerrigan D.F., Mitchell R.S. Number of ganglion cells in glaucoma eyes compared with threshold visual field tests in the same persons. Investigative Ophthalmology and Visual Science 2000, 41:741-748.
28. Kurtenbach A., Flogel W., Erb C. Anomaloscope matches in patients with diabetes mellitus. Graefes Archive for Clinical and Experimental Ophthalmology 2002, 240:79-84.
29. Li Q., Puro D.G. Diabetes-induced dysfunction of the glutamate transporter in retinal Muller cells. Investigative Ophthalmology and Visual Science 2002, 43:3109-3116.
30. Lopes de Faria J.M., Katsumi O., Cagliero E., Nathan D., Hirose T. Neurovisual abnormalities preceding the retinopathy in patients with long-term type 1 diabetes mellitus. Graefes Archive for Clinical and Experimental Ophthalmology 2001, 239:643-648.
31. Malmer L., Martin L. Microdot test of foveal function. A comparison with visual acuity at high and low contrast. Ophthalmic and Physiological Optics 2005, 25:81-86.
32. Martin P.M., Roon P., Van Ells T.K., Ganapathy V., Smith S.B. Death of retinal neurons in streptozotocin-induced diabetic mice. Investigative Ophthalmology and Visual Science 2004, 45:3330-3336.
33. Masland R.H. The fundamental plan of the retina. Nature Neuroscience 2001, 4:877-886.
34. Ng J.S., Bearse M.A., Schneck M.E., Barez S., Adams A.J. Local diabetic retinopathy prediction by multifocal ERG delays over 3years. Investigative Ophthalmology and Visual Science 2008, 49:1622-1628.
35. Nilsson M., Von W.G., Wanger P., Martin L. Early detection of macular changes in patients with diabetes using Rarebit Fovea Test and optical coherence tomography. British Journal of Ophthalmology 2007, 91:1596-1598.
36. Nilsson M., Wanger P., Martin L. Perception of very small visual stimuli in the fovea: normative data for the Rarebit Foveal Test. Clinical and Experimental Optometry 2006, 89:81-85.
37. Oshitari T., Hanawa K., Adachi-Usami E. Changes of macular and RNFL thicknesses measured by Stratus OCT in patients with early stage diabetes. Eye (Lond) 2009, 23:884-889.
38. Park S.H., Park J.W., Park S.J., Kim K.Y., Chung J.W., Chun M.H., et al. Apoptotic death of photoreceptors in the streptozotocin-induced diabetic rat retina. Diabetologia 2003, 46:1260-1268.
39. Realini T., Lai M.Q., Barber L. Impact of diabetes on glaucoma screening using frequency-doubling perimetry. Ophthalmology 2004, 111:2133-2136.
40. Rungger-Brandle E., Dosso A.A., Leuenberger P.M. Glial reactivity, an early feature of diabetic retinopathy. Investigative Ophthalmology and Visual Science 2000, 41:1971-1980.
41. Salvetat M.L., Zeppieri M., Parisi L., Brusini P. Rarebit perimetry in normal subjects: test-retest variability, learning effect, normative range, influence of optical defocus, and cataract extraction. Investigative Ophthalmology and Visual Science 2007, 48:5320-5331.
42. Strouthidis N.G., Vinciotti V., Tucker A.J., Gardiner S.K., Crabb D.P., Garway-Heath D.F. Structure and function in glaucoma: The relationship between a functional visual field map and an anatomic retinal map. Investigative Ophthalmology and Visual Science 2006, 47:5356-5362.
43. Tan O., Chopra V., Lu A.T., Schuman J.S., Ishikawa H., Wollstein G., et al. Detection of macular ganglion cell loss in glaucoma by Fourier-domain optical coherence tomography. Ophthalmology 2009, 116:2305-2314.
44. Tan O., Li G., Lu A.T., Varma R., Huang D. Mapping of macular substructures with optical coherence tomography for glaucoma diagnosis. Ophthalmology 2008, 115:949-956.
45. Van Dijk H.W., Kok P.H., Garvin M., Sonka M., DeVries J.H., Michels R.P., et al. Selective loss of inner retinal layer thickness in type 1 diabetic patients with minimal diabetic retinopathy. Investigative Ophthalmology and Visual Science 2009, 50:3404-3409.
46. Van Dijk H.W., Verbraak F.D., Kok P.H., Garvin M.K., Sonka M., Lee K., et al. Decreased retinal ganglion cell layer thickness in type 1 diabetic patients. Investigative Ophthalmology and Visual Science 2010, 51:3660-3665.
47. Wang M., Hood D.C., Cho J.S., Ghadiali Q., De Moraes G.V., Zhang X., et al. Measurement of local retinal ganglion cell layer thickness in patients with glaucoma using frequency-domain optical coherence tomography. Archives of Ophthalmology 2009, 127:875-881.
48. Wilkinson C.P., Ferris F.L., Klein R.E., Lee P.P., Agardh C.D., Davis M., et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003, 110:1677-1682.